KIDS

Over the past six months, OrthoPediatrics Corp.'s stock has been influenced by several events. On August 4, 2026, the company reported strong Q2 2026 earnings with record total revenue of $70.5 million (a 15% year-over-year increase) and increased its full-year 2026 revenue guidance, contributing to positive stock movement. New product launches and milestones, such as the introduction of OPSB® Knee 'TractorFIX on October 7, 2026, surpassing 1,000 PNP Tibia Nail implantations on September 22, 2026, and the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System on August 25, 2026, generally fostered positive investor sentiment. Conversely, insider selling totaling $46,747,931.00 in the past three months could be perceived negatively. As of October 2, 2026, analysts maintained a 'Moderate Buy' consensus rating with an average price target of $26.50, suggesting a potential upside. The stock itself increased by 21.9% from $17.76 on January 1st, 2026, to $21.65 by October 10, 2026, trading within a 52-week range of $14.42 to $26.74.